Peptide Almanac
Every compound listed across the nine leading peptide catalogues, deduplicated by alias into a single canonical list. Where an evidence review is complete, you get graded claims and the studies behind them. Where it is not, the entry says so rather than implying otherwise.
161
Compounds catalogued
24
Evidence reviews complete
137
Awaiting review
21
On all 9 catalogues
Showing 161 of 161 compounds · 24 with a completed evidence review
| 5-Amino-1MQ Small-molecule NNMT inhibitor (not a peptide) | Reviewed | Metabolic | DPreclinical | Unapproved research chemical | 0 / 1 | 8/9 |
|---|---|---|---|---|---|---|
| 9-Me-BC Beta-carboline alkaloid (not a peptide) | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| Abaloparatide PTHrP analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| ACE-031 Soluble activin receptor type IIB fusion protein | Not reviewed | Muscle | No evidence review | Not reviewed | — | 2/9 |
| Adalank Modified Selank analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| Adamax N-acetyl Semax analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 5/9 |
| Adipotide Proapoptotic peptidomimetic (FTPP) | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 5/9 |
| AHK-Cu Copper-binding tripeptide | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 3/9 |
| AICAR AMPK activator (not a peptide) | Not reviewed | Mitochondrial | No evidence review | Not reviewed | — | 3/9 |
| Alpha-MSH Endogenous melanocortin peptide | Not reviewed | Melanocortin | No evidence review | Not reviewed | — | 1/9 |
| Amycretin Investigational GLP-1/amylin co-agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 1/9 |
| Anserine Dipeptide (beta-alanyl-methylhistidine) | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| AOD-9604 Growth hormone C-terminal fragment (176-191) | Reviewed | Metabolic | BModerate | Not approved for human use | 1 / 1 | 9/9 |
| ARA-290 Erythropoietin-derived peptide (cibinetide) | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 8/9 |
| Argireline Acetyl hexapeptide-8 | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 2/9 |
| Astressin-B CRF receptor antagonist | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| B12 Methylcobalamin Vitamin B12 form (not a peptide) | Not reviewed | Other | No evidence review | Not reviewed | — | 3/9 |
| B7-33 Relaxin analogue | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| BAM15 Mitochondrial uncoupler (not a peptide) | Not reviewed | Mitochondrial | No evidence review | Not reviewed | — | 3/9 |
| BPC-157 Synthetic pentadecapeptide derived from a gastric protein sequence | Reviewed | Repair | DPreclinical | Unapproved research chemical | 2 / 3 | 9/9 |
| Bremelanotide Melanocortin receptor agonist | Reviewed | Melanocortin | AStrong | FDA-approved | 2 / 2 | 9/9 |
| Bronchogen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 1/9 |
| Cagrilintide Long-acting amylin analogue | Reviewed | Amylin | CPreliminary | Investigational | 5 / 5 | 8/9 |
| CagriSema Cagrilintide + semaglutide combination | Not reviewed | Incretin | No evidence review | Not reviewed | — | 4/9 |
| Calcitonin Thyroid hormone peptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Carbetocin Oxytocin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Cardiogen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 4/9 |
| Cartalax Peptide bioregulator (Ala-Glu-Asp-Pro) | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 6/9 |
| Cerebrolysin Porcine brain-derived peptide preparation | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 7/9 |
| Cerluten Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 1/9 |
| Cetrorelix GnRH antagonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Chonluten Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 2/9 |
| CJC-1295 GHRH analogue, supplied with or without a drug-affinity complex | Reviewed | GH axis | CPreliminary | Unapproved research chemical | 1 / 1 | 8/9 |
| Cortagen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| Cortexin Bovine brain-derived peptide preparation | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| Davunetide NAP octapeptide | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| Degarelix GnRH antagonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Desmopressin Vasopressin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Dihexa Angiotensin IV analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 5/9 |
| DNSP-11 Dopamine neuron stimulating peptide | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| DSIP Nonapeptide | Reviewed | Sleep | XInsufficient / conflicting | Unapproved research chemical | 1 / 1 | 9/9 |
| Dulaglutide GLP-1 receptor agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 2/9 |
| Ecnoglutide Investigational GLP-1 receptor agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 1/9 |
| Efpeglenatide Investigational GLP-1 receptor agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 1/9 |
| Elamipretide (SS-31) Cardiolipin-binding tetrapeptide | Reviewed | Mitochondrial | XInsufficient / conflicting | Investigational | 1 / 1 | 7/9 |
| Eloralintide Investigational amylin analogue | Not reviewed | Amylin | No evidence review | Not reviewed | — | 1/9 |
| Enfuvirtide HIV fusion inhibitor peptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Epitalon Synthetic tetrapeptide (Ala-Glu-Asp-Gly) | Reviewed | Longevity | XInsufficient / conflicting | Unapproved research chemical | 1 / 1 | 9/9 |
| Exenatide GLP-1 receptor agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 2/9 |
| FGL NCAM-derived peptide | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 1/9 |
| Follistatin-315 Follistatin isoform | Not reviewed | Muscle | No evidence review | Not reviewed | — | 2/9 |
| Follistatin-344 Follistatin isoform | Not reviewed | Muscle | No evidence review | Not reviewed | — | 5/9 |
| FOXO4-DRI Senolytic D-retro-inverso peptide | Not reviewed | Longevity | No evidence review | Not reviewed | — | 8/9 |
| GDF-8 (Myostatin) Growth differentiation factor 8 | Not reviewed | Muscle | No evidence review | Not reviewed | — | 1/9 |
| GHK Gly-His-Lys tripeptide | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 2/9 |
| GHK-Cu Copper-binding tripeptide complex | Reviewed | Dermatologic | CPreliminary | Not approved for human use | 2 / 3 | 9/9 |
| GHRH Growth-hormone-releasing hormone | Not reviewed | GH axis | No evidence review | Not reviewed | — | 1/9 |
| GHRP-1 Growth hormone secretagogue | Not reviewed | GH axis | No evidence review | Not reviewed | — | 1/9 |
| GHRP-2 Growth hormone secretagogue | Not reviewed | GH axis | No evidence review | Not reviewed | — | 6/9 |
| GHRP-6 Growth hormone secretagogue | Not reviewed | GH axis | No evidence review | Not reviewed | — | 8/9 |
| Glatiramer Acetate Random amino acid copolymer | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| GLOW Blend Multi-compound blend (GHK-Cu / BPC-157 / TB-500) | Not reviewed | Blend | No evidence review | Not reviewed | — | 6/9 |
| Glutathione Tripeptide antioxidant | Not reviewed | Other | No evidence review | Not reviewed | — | 9/9 |
| Gonadorelin GnRH (1-10) | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 5/9 |
| Goserelin GnRH agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Hexarelin Synthetic hexapeptide growth hormone secretagogue | Reviewed | GH axis | CPreliminary | Unapproved research chemical | 0 / 0 | 7/9 |
| HGH (Somatropin) Recombinant human growth hormone | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| hGH Fragment 176-191 Growth hormone C-terminal fragment | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 5/9 |
| Histrelin GnRH agonist implant | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Humanin Mitochondrial-derived peptide | Not reviewed | Mitochondrial | No evidence review | Not reviewed | — | 7/9 |
| Icatibant Bradykinin B2 receptor antagonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| IGF-1 DES Truncated IGF-1 analogue | Not reviewed | Muscle | No evidence review | Not reviewed | — | 1/9 |
| IGF-1 LR3 Long R3 IGF-1 analogue | Not reviewed | Muscle | No evidence review | Not reviewed | — | 7/9 |
| Ipamorelin Selective growth hormone secretagogue (ghrelin receptor agonist) | Reviewed | GH axis | EMechanistic | Unapproved research chemical | 2 / 3 | 9/9 |
| Kisspeptin-10 KISS1-derived decapeptide | Not reviewed | Other | No evidence review | Not reviewed | — | 8/9 |
| KLOW Blend Multi-compound blend (KPV / BPC-157 / TB-500 / GHK-Cu) | Not reviewed | Blend | No evidence review | Not reviewed | — | 8/9 |
| KPV Alpha-MSH C-terminal tripeptide | Not reviewed | Immune | No evidence review | Not reviewed | — | 9/9 |
| L-Carnitine Quaternary ammonium compound (not a peptide) | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 5/9 |
| L-Carnosine Beta-alanyl-L-histidine dipeptide | Not reviewed | Other | No evidence review | Not reviewed | — | 2/9 |
| L-Theanine Amino acid analogue (not a peptide) | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| Lactoferrin Iron-binding glycoprotein | Not reviewed | Immune | No evidence review | Not reviewed | — | 1/9 |
| Lanreotide Somatostatin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Larazotide Zonulin antagonist octapeptide | Not reviewed | Other | No evidence review | Not reviewed | — | 3/9 |
| Leuprolide GnRH agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Linaclotide Guanylate cyclase-C agonist peptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Lipo-C Blend Lipotropic injection blend (not a peptide) | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 6/9 |
| Liraglutide GLP-1 receptor agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 3/9 |
| Livagen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| Lixisenatide GLP-1 receptor agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| LL-37 Cathelicidin antimicrobial peptide | Not reviewed | Immune | No evidence review | Not reviewed | — | 7/9 |
| Magnesium L-Threonate Magnesium salt (not a peptide) | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| Maridebart Cafraglutide Investigational GIPR antagonist / GLP-1 agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 1/9 |
| Matrixyl Palmitoyl pentapeptide-4 | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 2/9 |
| Mazdutide GLP-1 / glucagon dual agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 6/9 |
| mcIRBP-19 Bitter melon-derived peptide | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 1/9 |
| Melanotan I Alpha-MSH analogue (afamelanotide) | Not reviewed | Melanocortin | No evidence review | Not reviewed | — | 4/9 |
| Melanotan II Non-selective melanocortin receptor agonist | Reviewed | Melanocortin | CPreliminary | Unapproved research chemical | 1 / 1 | 9/9 |
| Methylene Blue Thiazine dye (not a peptide) | Not reviewed | Mitochondrial | No evidence review | Not reviewed | — | 4/9 |
| MGF Mechano growth factor (IGF-1Ec) | Not reviewed | Muscle | No evidence review | Not reviewed | — | 5/9 |
| MK-677 Non-peptide growth hormone secretagogue | Not reviewed | GH axis | No evidence review | Not reviewed | — | 3/9 |
| Mod GRF 1-29 GHRH (1-29) analogue, no DAC | Not reviewed | GH axis | No evidence review | Not reviewed | — | 5/9 |
| MOTS-c Mitochondrial-derived peptide (16 amino acids) | Reviewed | Mitochondrial | DPreclinical | Unapproved research chemical | 1 / 2 | 9/9 |
| N-Acetyl Epithalon Amidate Modified Epitalon analogue | Not reviewed | Longevity | No evidence review | Not reviewed | — | 2/9 |
| N-Acetyl Selank Amidate Modified Selank analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 2/9 |
| N-Acetyl Semax Amidate Modified Semax analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 3/9 |
| NAD+ and precursors Coenzyme and its biosynthetic precursors (not a peptide) | Reviewed | Longevity | BModerate | Not approved for human use | 1 / 1 | 8/9 |
| NADH Reduced NAD (not a peptide) | Not reviewed | Longevity | No evidence review | Not reviewed | — | 1/9 |
| Nafarelin GnRH agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Noopept Dipeptide nootropic (not a classical peptide drug) | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 2/9 |
| Octreotide Somatostatin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Orexin-A Hypothalamic neuropeptide | Not reviewed | Sleep | No evidence review | Not reviewed | — | 1/9 |
| Orforglipron Investigational oral non-peptide GLP-1 agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 4/9 |
| Ovagen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 2/9 |
| Oxytocin Nonapeptide hormone | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 8/9 |
| P21 Ciliary neurotrophic factor peptide mimetic | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 5/9 |
| Palmitoyl Tetrapeptide-7 Cosmetic tetrapeptide | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 1/9 |
| Palopegteriparatide Long-acting PTH prodrug | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Pancragen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 2/9 |
| Pasireotide Somatostatin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| PE-22-28 Spadin analogue | Not reviewed | Neurologic | No evidence review | Not reviewed | — | 5/9 |
| PEG-MGF Pegylated mechano growth factor | Not reviewed | Muscle | No evidence review | Not reviewed | — | 4/9 |
| Pemvidutide Investigational GLP-1 / glucagon dual agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 1/9 |
| Petrelintide Investigational amylin analogue | Not reviewed | Amylin | No evidence review | Not reviewed | — | 1/9 |
| Pinealon Peptide bioregulator (Glu-Asp-Arg) | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 9/9 |
| Plecanatide Guanylate cyclase-C agonist peptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| PNC-27 p53-derived membrane-disrupting peptide | Not reviewed | Other | No evidence review | Not reviewed | — | 3/9 |
| Pramlintide Amylin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Prostamax Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| Retatrutide Triple GIP/GLP-1/glucagon receptor agonist | Reviewed | Incretin | CPreliminary | Investigational | 2 / 2 | 9/9 |
| Secretin Gastrointestinal hormone peptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Selank Synthetic heptapeptide tuftsin analogue | Reviewed | Neurologic | CPreliminary | Not approved for human use | 2 / 2 | 9/9 |
| Semaglutide GLP-1 receptor agonist (acylated 31-amino-acid analogue) | Reviewed | Incretin | AStrong | FDA-approved | 2 / 2 | 9/9 |
| Semax Synthetic ACTH fragment analogue | Reviewed | Neurologic | CPreliminary | Not approved for human use | 2 / 2 | 9/9 |
| Sermorelin GHRH (1-29) analogue | Reviewed | GH axis | BModerate | Withdrawn or restricted | 1 / 1 | 9/9 |
| Setmelanotide MC4R agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| SLU-PP-332 ERR agonist (not a peptide) | Not reviewed | Mitochondrial | No evidence review | Not reviewed | — | 7/9 |
| SNAP-8 Acetyl octapeptide-3 | Not reviewed | Dermatologic | No evidence review | Not reviewed | — | 8/9 |
| Survodutide GLP-1 / glucagon dual agonist | Not reviewed | Incretin | No evidence review | Not reviewed | — | 7/9 |
| TB-500 / Thymosin beta-4 Actin-sequestering peptide (TB-500 is a fragment, not the full protein) | Reviewed | Repair | DPreclinical | Unapproved research chemical | 2 / 3 | 9/9 |
| Teduglutide GLP-2 analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Teriparatide PTH(1-34) | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Terlipressin Vasopressin analogue | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Tesamorelin Growth-hormone-releasing factor analogue | Reviewed | GH axis | AStrong | FDA-approved (different indication) | 1 / 1 | 9/9 |
| Tesofensine Triple monoamine reuptake inhibitor (not a peptide) | Not reviewed | Metabolic | No evidence review | Not reviewed | — | 3/9 |
| Testagen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| Thymagen Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 1/9 |
| Thymalin Thymic peptide extract | Not reviewed | Immune | No evidence review | Not reviewed | — | 5/9 |
| Thymogen Thymic dipeptide (Glu-Trp) | Not reviewed | Immune | No evidence review | Not reviewed | — | 2/9 |
| Thymopentin Thymopoietin fragment (32-36) | Not reviewed | Immune | No evidence review | Not reviewed | — | 1/9 |
| Thymosin alpha-1 28-amino-acid thymic peptide | Reviewed | Immune | BModerate | Not approved for human use | 0 / 0 | 9/9 |
| Thymulin Zinc-dependent thymic hormone | Not reviewed | Immune | No evidence review | Not reviewed | — | 2/9 |
| Tirzepatide Dual GIP/GLP-1 receptor agonist | Reviewed | Incretin | AStrong | FDA-approved | 2 / 2 | 9/9 |
| TRH Thyrotropin-releasing hormone | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| Triptorelin GnRH agonist | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 2/9 |
| TUDCA Bile acid (not a peptide) | Not reviewed | Other | No evidence review | Not reviewed | — | 1/9 |
| Vasopressin Antidiuretic hormone nonapeptide | Not reviewed | Approved medicine | No evidence review | Not reviewed | — | 1/9 |
| Vesilute Peptide bioregulator | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 2/9 |
| Vesugen Peptide bioregulator (Lys-Glu-Asp) | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| Vilon Peptide bioregulator (Lys-Glu) | Not reviewed | Bioregulator | No evidence review | Not reviewed | — | 3/9 |
| VIP Vasoactive intestinal peptide | Not reviewed | Other | No evidence review | Not reviewed | — | 8/9 |
| Wolverine Blend Multi-compound blend (BPC-157 / TB-500) | Not reviewed | Blend | No evidence review | Not reviewed | — | 3/9 |
“Reviewed” and “Not reviewed” are the important column
24 of 161 compounds have a completed evidence review with graded claims and a study register. The other 137 are catalogue entries: we record what the compound is and who sells it, and nothing more. No grade, no quantity, no claim. Coverage is not knowledge, and we will not let breadth imply depth.
Market prevalence is a commercial signal, not a scientific one
The bar in the last column counts how many of the nine catalogues list a compound. It measures how widely something is sold. A compound appearing on all nine while carrying grade X evidence is not well supported; it is well distributed. That gap is often the most useful thing on this page.
What is deliberately absent
Several of the reference sites also sell SARMs, prescription pharmaceuticals, and hormones. None of those are peptides, so none are catalogued here. Compounds that are not peptides but are consistently researched alongside them are included and labelled as such in their molecule class.